Serelaxin, recombinant human relaxin-2, for heart failure patients A systematic review and meta-analysis | |
Yu, Ling[1]; Cao, Lijuan[1]; Sun, Jing[2]; Li, Zhongyi[3]; Yao, Fengzhen[1]; Zhou, Yabin[2] | |
2018 | |
卷号 | 97期号:25 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4765310 |
专题 | 暨南大学 |
作者单位 | 1.[1]Heilongjiang Univ Tradit Chinese Med, Harbin, Heilongjiang, Peoples R China 2.[2]Heilongjiang Univ Chinese Med, Affiliated Hosp 1, Dept Cardiovasc 2, Harbin, Heilongjiang, Peoples R China 3.[3]Jinan Univ, Clin Med Coll 1, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China |
推荐引用方式 GB/T 7714 | Yu, Ling[1],Cao, Lijuan[1],Sun, Jing[2],et al. Serelaxin, recombinant human relaxin-2, for heart failure patients A systematic review and meta-analysis[J],2018,97(25). |
APA | Yu, Ling[1],Cao, Lijuan[1],Sun, Jing[2],Li, Zhongyi[3],Yao, Fengzhen[1],&Zhou, Yabin[2].(2018).Serelaxin, recombinant human relaxin-2, for heart failure patients A systematic review and meta-analysis.,97(25). |
MLA | Yu, Ling[1],et al."Serelaxin, recombinant human relaxin-2, for heart failure patients A systematic review and meta-analysis".97.25(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论